We are live on ! Find out more
CM

Castleark Management Portfolio holdings

AUM $3.71B
1-Year Est. Return 65.19%
This Fund
S&P 500
This Quarter Est. Return
+20.94%
1 Year Est. Return
+65.19%
3 Year Est. Return
+247.97%
5 Year Est. Return
+412.62%
10 Year Est. Return
+3,903.2%
AUM
$2.66B
AUM Growth
+$310M
Cap. Flow
-$54M
Cap. Flow %
-2.03%
Top 10 Hldgs %
18.8%
Holding
435
New
70
Increased
72
Reduced
125
Closed
75

Top Buys

Rank Stock Value
1
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$69.2M
2
CSX icon
CSX Corp
CSX
+$32.5M
3
BABA icon
Alibaba
BABA
+$31.6M
4
CTAS icon
Cintas
CTAS
+$26.2M
5
INTU icon
Intuit
INTU
+$21.7M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$26M
2
UNH icon
UnitedHealth
UNH
+$26M
3
EOG icon
EOG Resources
EOG
+$24.5M
4
JBHT icon
JB Hunt Transport Services
JBHT
+$23.8M
5
CAT icon
Caterpillar
CAT
+$21.6M

Sector Composition

Rank Sector Weight
1 Technology 21.6%
2 Healthcare 16.93%
3 Consumer Discretionary 13.71%
4 Industrials 12.39%
5 Energy 9.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GDOT icon
376
Green Dot
GDOT
$752M
-157,799
Closed -$12.5M
HAE icon
377
Haemonetics
HAE
$4.83B
-113,412
Closed -$11.3M
HCSG icon
378
Healthcare Services Group
HCSG
$1.5B
-157,740
Closed -$6.34M
HELE icon
379
Helen of Troy
HELE
$628M
-53,375
Closed -$7M
KBR icon
380
KBR
KBR
$4.7B
-329,250
Closed -$5M
LDOS icon
381
Leidos
LDOS
$16.2B
-47,585
Closed -$2.51M
LGND icon
382
Ligand Pharmaceuticals
LGND
$5.52B
-63,759
Closed -$5.4M
LIVN icon
383
LivaNova
LIVN
$4.38B
-69,285
Closed -$6.34M
LPSN
384
DELISTED
LivePerson
LPSN
-7,368
Closed -$2.08M
MKC icon
385
McCormick & Company Non-Voting
MKC
$13.4B
-6,580
Closed -$458K
MS icon
386
Morgan Stanley
MS
$324B
-322,429
Closed -$12.8M
NBIX icon
387
Neurocrine Biosciences
NBIX
$15.2B
-15,775
Closed -$1.13M
NDLS icon
388
Noodles & Co
NDLS
$81.2M
-68,990
Closed -$3.86M
NDSN icon
389
Nordson
NDSN
$17.2B
-1,940
Closed -$232K
NNN icon
390
NNN REIT
NNN
$8.29B
-59,565
Closed -$2.89M
NVEE
391
DELISTED
NV5 Global
NVEE
-561,740
Closed -$8.5M
NVRI icon
392
Enviri
NVRI
$606M
-215,165
Closed -$4.27M
OC icon
393
Owens Corning
OC
$10.2B
-96,985
Closed -$4.26M
PCRX icon
394
Pacira BioSciences
PCRX
$960M
-119,440
Closed -$5.14M
PLAY icon
395
Dave & Buster's
PLAY
$239M
-115,770
Closed -$5.16M
PVH icon
396
PVH
PVH
$3.3B
-71,399
Closed -$6.64M
QNST icon
397
QuinStreet
QNST
$1.05B
-331,624
Closed -$5.38M
SCI icon
398
Service Corp International
SCI
$11.1B
-57,030
Closed -$2.3M
SNBR
399
DELISTED
Sleep Number
SNBR
-123,457
Closed -$3.92M
SQM icon
400
Sociedad Química y Minera de Chile
SQM
$19.8B
-13,530
Closed -$518K

Similar funds

Castleark Management's Q1 2019 Portfolio in Review

As of Q1 2019, Castleark Management held 435 positions worth $2.66B, up 13% from $2.35B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Castleark Management's Q1 2019 filing shows 70 new, 72 increased, 125 reduced and 75 closed positions. Its largest new stake was CSX Corp: 1,401,555 shares worth $35M. The largest sale was Eli Lilly, an estimated $26M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Castleark Management's largest Q1 2019 buy was CSX Corp: 1,401,555 shares worth $35M.
  • Castleark Management added most to iShares MSCI Emerging Markets ETF in Q1 2019, an estimated $69.2M increase.
  • Castleark Management's biggest Q1 2019 reduction was Eli Lilly, cutting an estimated $26M.
  • Castleark Management fully exited Align Technology in Q1 2019, selling an estimated $14M.
  • Castleark Management's ten largest holdings make up 19% of its $2.66B portfolio in Q1 2019.
  • Castleark Management opened 70 new positions and closed 75 in Q1 2019.
  • Castleark Management's portfolio value rose 13% quarter-over-quarter to $2.66B.

Based on Castleark Management's 13F filing for Q1 2019, filed 14 May 2019.